» Authors » I L Paradis

I L Paradis

Explore the profile of I L Paradis including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 70
Citations 570
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Paradis I, Si L, Rabin B, Van Thiel D, Starzl T, Rosenthal T, et al.
Transplant Proc . 2010 Dec; 15(3):1912-1914. PMID: 21151797
No abstract available.
2.
Martinez J, Paradis I, Dauber J, Grgurich W, Richards T, Yousem S, et al.
Am J Respir Crit Care Med . 1997 Jan; 155(1):285-90. PMID: 9001326
To clarify the usefulness of spirometry to assess the function of the lung allograft post-transplant, we retrospectively reviewed 351 sequential spirometry measurements performed by 65 healthy recipients after the 80th...
3.
Iacono A, Keenan R, Duncan S, Smaldone G, Dauber J, Paradis I, et al.
Am J Respir Crit Care Med . 1996 Apr; 153(4 Pt 1):1451-5. PMID: 8616581
This study evaluated aerosolized cyclosporine as rescue therapy for lung transplant recipients with unremitting chronic rejection. Nine patients with histologic active obliterative bronchiolitis and progressively worsening airway obstruction refractory to...
4.
Guilinger R, Paradis I, Dauber J, Yousem S, Williams P, Keenan R, et al.
Am J Respir Crit Care Med . 1995 Dec; 152(6 Pt 1):2037-43. PMID: 8520773
Medical and surgical advances have made lung transplantation a feasible therapy for end-stage lung disease. Fiberoptic bronchoscopy with bronchoalveolar lavage (BAL) and transbronchial lung biopsy (TBBx) is an accepted technique...
5.
Keenan R, Konishi H, Kawai A, Paradis I, Nunley D, Iacono A, et al.
Ann Thorac Surg . 1995 Sep; 60(3):580-4; discussion 584-5. PMID: 7545889
Background: A prospective clinical trial was undertaken to compare the efficacy of tacrolimus (FK 506) versus cyclosporine as the primary immunosuppressive agent after lung transplantation. Methods: Between October 1991 and...
6.
Keenan R, Zeevi A, Iacono A, Spichty K, Cai J, Yousem S, et al.
Surgery . 1995 Aug; 118(2):385-91. PMID: 7638755
Background: Refractory rejection is a major cause of morbidity and death among lung transplant recipients. Traditional rescue therapies have proved only modestly successful. We recently demonstrated the safety of inhaled...
7.
Bando K, Paradis I, Similo S, Konishi H, Komatsu K, Zullo T, et al.
J Thorac Cardiovasc Surg . 1995 Jul; 110(1):4-13; discussion 13-4. PMID: 7609567
With a prevalence of 34% (55/162 at-risk recipients) and a mortality of 25% (14/55 affected recipients), obliterative bronchiolitis is the most significant long-term complication after pulmonary transplantation. Because of its...
8.
Bando K, Paradis I, Keenan R, Yousem S, Komatsu K, Konishi H, et al.
J Heart Lung Transplant . 1995 Jul; 14(4):692-8. PMID: 7578177
Background And Methods: To determine the long-term functional outcome for single versus bilateral lung transplant for nonseptic obstructive lung disease, we compared the results from 39 single and nine bilateral...
9.
Zenati M, Keenan R, Landreneau R, Paradis I, Ferson P, Griffith B
Ann Thorac Surg . 1995 Jun; 59(6):1581-3. PMID: 7771852
We present a case of bridging to lung transplantation by means of laser ablation of emphysematous bullae in a lung transplant candidate. The patient underwent successful left single-lung transplantation 17...
10.
Kawai A, Paradis I, Keenan R, Yamazaki K, Yousem S, Ohori N, et al.
Transplant Proc . 1995 Feb; 27(1):1288-9. PMID: 7878885
No abstract available.